Toxin plasmids of Clostridium perfringens

Microbiology and Molecular Biology Reviews

Volumn 77, Issue 2, 2013, Pages 208-233

  Li, Jihong ^a   Adams, Vicki ^b   Bannam, Trudi L ^b   Miyamoto, Kazuaki ^c   Garcia, Jorge P ^d   Uzal, Francisco A ^d   Rood, Julian I ^b   McClane, Bruce A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MONASH UNIVERSITY   (Australia)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; BACTERIOCIN; BETA TOXIN; CLOSTRIDIUM PERFRINGENS TOXIN; CLOSTRIDIUM TOXIN; EPSILON TOXIN; HELICASE; HERMES ANTIGEN; IOTA TOXIN; MEMBRANE PROTEIN; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; CLOSTRIDIUM PERFRINGENS; DIARRHEA; ENTERITIS; ENTEROTOXEMIA; FOOD POISONING; GAS GANGRENE; GENE INSERTION SEQUENCE; GENE SEQUENCE; HUMAN; INTESTINE FLORA; NECROTIZING ENTERITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PLASMID; PROMOTER REGION; REVIEW; VACCINATION;

ANIMALS; BACTERIAL TOXINS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; ENTERITIS; ENTEROTOXEMIA; ENTEROTOXINS; GENES, BACTERIAL; HUMANS; PLASMIDS; VIRULENCE;

EID: 84878250366     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00062-12     Document Type: Review

References (260)

1. McClane BA, Robertson SL, Li J. 2013. Clostridium perfringens, p 465-489. In Doyle MP, Buchanan RL (ed), Food microbiology: fundamentals and frontiers, 4th ed. ASM Press, Washington, DC.
2. Labbe RG. 1989. Clostridium perfringens, p 192-234. In Doyle MP (ed), Foodborne bacterial pathogens. Marcel Decker, New York, NY.
3. McClane BA, Uzal FA, Miyakawa MF, Lyerly D, Wilkins TD. 2006. The enterotoxic clostridia, p 688-752. In Dworkin M, Falkow S, Rosenburg E, Schleifer H, Stackebrandt E (ed), The prokaryotes: a handbook on the biology of bacteria, 3rd ed. Springer, New York, NY.
4. Rood JI. 2006. Clostridium perfringens and histotoxic disease, p 753-770. In Dworkin M, Falkow S, Rosenburg E, Schleifer H, Stackebrandt E (ed), The prokaryotes: a handbook on the biology of bacteria, 3rd ed. Springer, New York, NY.
5. Titball RW, Rood JI. 2002. Clostridium perfringens: wound infections, p 1875-1903. In Sussman M (ed), Molecular medical microbiology. Academic Press, London, England.
6. Songer JG. 1996. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 9:216-234. (Pubitemid 26124457)
7. Hatheway C. 1990. Toxigenic clostridia. Clin. Microbiol. Rev. 3:66-76.
8. McDonel JL. 1986. Toxins of Clostridium perfringens types A, B, C, D, and E, p 477-517. In Dorner F, Drews H (ed), Pharmacology of bacterial toxins. Pergamon Press, Oxford, England.
9. Petit L, Gilbert M, Popoff M. 1999. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 7:104-110. (Pubitemid 29271996)
10. Animoto K, Noro T, Oishi E, Shimizu M. 2007. A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C. Microbiology 153:1198-1206. (Pubitemid 46605818)
11. Keyburn AL, Boyce JD, Vaz P, Bannam TL, Ford ME, Parker D, Di Rubbo A, Rood JI, Moore RJ. 2008. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. 4:e26. doi:10.1371/journal.ppat.0040026.
12. Sarker MR, Carman RJ, McClane BA. 1999. Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol. Microbiol. 33:946-958. (Pubitemid 29425247)
13. Miyamoto K, Fisher DJ, Li J, Sayeed S, Akimoto S, McClane BA. 2006. Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates. J. Bacteriol. 188:1585-1598. (Pubitemid 43228692)
14. Miyamoto K, Li J, Sayeed S, Akimoto S, McClane BA. 2008. Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid. J. Bacteriol. 190:7178-7188.
15. Sayeed S, Li J, McClane BA. 2007. Virulence plasmid diversity in Clostridium perfringens type D isolates. Infect. Immun. 75:2391-2398. (Pubitemid 46744329)
16. Sayeed S, Li J, McClane BA. 2010. Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates. Infect. Immun. 78:495-504.
17. Gurjar A, Li J, McClane BA. 2010. Characterization of toxin plasmids in Clostridium perfringens type C isolates. Infect. Immun. 78:4860-4869.
18. Li J, Miyamoto K, McClane BA. 2007. Comparison of virulence plasmids among Clostridium perfringens type E isolates. Infect. Immun. 75:1811-1819. (Pubitemid 46559449)
19. Bannam T, Yan X, Harrison P, Seemann T, Keyburn A, Stubenrauch C, Weeramantri L, Chueng J, McClane B, Boyce J, Moore R, Rood J. 2011. Necrotic enteritis-derived Clostridium perfringens strain with three closely related independently conjugative toxin and antibiotic plasmids. mBio 2(5):e00190-11. doi:10.1128/mBio.00190-11.
20. Fisher DJ, Miyamoto K, Harrison B, Akimoto S, Sarker MR, McClane BA. 2005. Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Mol. Microbiol. 56:747-762. (Pubitemid 40562367)
21. Hughes ML, Poon R, Adams V, Sayeed S, Saputo J, Uzal FA, McClane BA, Rood JI. 2007. Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative. J. Bacteriol. 189:7531-7538. (Pubitemid 350035061)
22. Billington SJ, Wieckowski EU, Sarker MR, Bueschel D, Songer JG, McClane BA. 1998. Clostridium perfringens type E animal enteritis isolates with highly conserved, silent enterotoxin sequences. Infect. Immun. 66:4531-4536. (Pubitemid 28402738)
23. Miyamoto K, Yumine N, Mimura K, Nagahama M, Li J, McClane BA, Akimoto S. 2011. Identification of novel Clostridium perfringens type E strains that carry an iota toxin plasmid with a functional enterotoxin gene. PLoS One 6:e20376. doi:10.1371/journal.pone.0020376.
24. Lepp D, Roxas B, Parreira V, Marri P, Rosey E, Gong J, Songer J, Vedantam G, Prescott J. 2010. Identification of novel pathogenicity loci in Clostridium perfringens strains that cause avian necrotic enteritis. PLoS One 5:e10795. doi:10.1371/journal.pone.0010795.
25. Myers GS, Rasko DA, Cheung JK, Ravel J, Seshadri R, DeBoy RT, Ren Q, Varga J, Awad MM, Brinkac LM, Daugherty SC, Haft DH, Dodson RJ, Madupu R, Nelson WC, Rosovitz MJ, Sullivan SA, Khouri H, Dimitrov GI, Watkins KL, Mulligan S, Benton J, Radune D, Fisher DJ, Atkins HS, Hiscox T, Jost BH, Billington SJ, Songer JG, McClane BA, Titball RW, Rood JI, Melville SB, Paulsen IT. 2006. Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res. 16:1031-1040. (Pubitemid 44162262)
26. Li J, Miyamoto K, Sayeed S, McClane BA. 2010. Organization of the cpe locus in CPE-positive Clostridium perfringens type C and D isolates. PLoS One 5:e10932. doi:10.1371/journal.pone.0010932.
27. Shimizu T, Ohtani K, Hirakawa H, Ohshima K, Yamashita A, Shiba T, Ogasawara N, Hattori M, Kuhara S, Hayashi H. 2002. Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc. Natl. Acad. Sci. U. S. A. 99:996-1001. (Pubitemid 34106624)
28. Gibert M, Jolivet-Reynaud C, Popoff MR. 1997. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene 203:65-73. (Pubitemid 27520654)
29. Gill DM. 1982. Bacterial toxins: a table of lethal amounts. Microbiol. Rev. 46:86-94. (Pubitemid 12101491)
30. Titball RW, Naylor CE, Basak AK. 1999. The Clostridium perfringens alpha-toxin. Anaerobe 5:51-64.
31. Sakurai J, Nagahama M, Oda M. 2004. Clostridium perfringens alpha-toxin: characterization and mode of action. J. Biochem. (Tokyo) 136:569-574. (Pubitemid 40364178)
32. Naylor CE, Eaton JT, Howells A, Justin N, Moss DS, Titball RW, Basak AK. 1998. Structure of the key toxin in gas gangrene. Nat. Struct. Biol. 5:738-746. (Pubitemid 28359811)
33. Williamson ED, Titball RW. 1993. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine 11:1253-1258. (Pubitemid 23308784)
34. Neeson BN, Clark GC, Atkins HS, Lingard B, Titball RW. 2007. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C. Microb. Pathog. 43:161-165. (Pubitemid 47198416)
35. Goni FM, Alonso A. 2002. Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 531:38-46. (Pubitemid 35232782)
36. Monturiol-Gross L, Flores-Diaz M, Araya-Castillo C, Pineda-Padilla MJ, Clark GC, Titball RW, Alape-Giron A. 2012. Reactive oxygen species and the MEK/ERK pathway are involved in the toxicity of Clostridium perfringens alpha-toxin, a prototype bacterial phospholipase C. J. Infect. Dis. 206:1218-1226.
37. Oda M, Ikari S, Matsuno T, Morimune Y, Nagahama M, Sakurai J. 2006. Signal transduction mechanism involved in Clostridium perfringens alpha-toxin-induced superoxide anion generation in rabbit neutrophils. Infect. Immun. 74:2876-2886. (Pubitemid 43672998)
38. Oda M, Kabura M, Takagishi T, Suzue A, Tominaga K, Urano S, Nagahama M, Kobayashi K, Furukawa K, Sakurai J. 2012. Clostridium perfringens alpha-toxin recognizes the GM1a-TrkA complex. J. Biol. Chem. 287:33070-33079.
39. Deguchi A, Miyamoto K, Kuwahara T, Kaneko I, Li J, McClane BA, Akimoto S. 2009. Genetic characterization of type A entertoxigenic Clostridium perfringens strains. PLoS One 4:e5598. doi:10.1371/journal.pone.0005598.
40. Ma M, Li J, McClane B. 2012. Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post-World War II Germany. Infect. Immun. 80:4354-4363.
41. Tweten RK. 2005. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 73:6199-6209. (Pubitemid 41368781)
42. Gilbert RJ. 2010. Cholesterol-dependent cytolysins. Adv. Exp. Med. Biol. 677:56-66.
43. Dunstone MA, Tweten RK. 2012. Packing a punch: the mechanism of pore formation by cholesterol dependent cytolysins and membrane attack complex/perforin-like proteins. Curr. Opin. Struct. Biol. 22:342-349.
44. Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW. 1997. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 89:685-692. (Pubitemid 27516171)
45. Shatursky O, Heuck AP, Shepard LA, Rossjohn J, Parker MW, Johnson AE, Tweten RK. 1999. The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell 99:293-299. (Pubitemid 29519908)
46. Awad MM, Bryant AE, Stevens DL, Rood JI. 1995. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Mol. Microbiol. 15:191-202.
47. Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, Finegold S, Guth PH, Stevens DL. 2000. Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J. Infect. Dis. 182:808-815.
48. Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, Finegold S, Guth PH, Stevens DL. 2000. Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J. Infect. Dis. 182:799-807.
49. Park JM, Ng VH, Maeda S, Rest RF, Karin M. 2004. Anthrolysin O and other gram-positive cytolysins are Toll-like receptor 4 agonists. J. Exp. Med. 200:1647-1655. (Pubitemid 40094188)
50. Fisher DJ, Fernandez-Miyakawa ME, Sayeed S, Poon R, Adams V, Rood JI, Uzal FA, McClane BA. 2006. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect. Immun. 74:5200-5210. (Pubitemid 44300439)
51. Collie RE, McClane BA. 1998. Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with nonfood-borne human gastrointestinal diseases. J. Clin. Microbiol. 36:30-36. (Pubitemid 28047428)
52. Fernandez-Miyakawa ME, Fisher DJ, Poon R, Sayeed S, Adams V, Rood JI, McClane BA, Uzal FA. 2007. Both epsilon-toxin and beta-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model. Infect. Immun. 75:1443-1452. (Pubitemid 46385838)
53. Czeczulin JR, Hanna PC, McClane BA. 1993. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect. Immun. 61:3429-3439. (Pubitemid 23223436)
54. Briggs DC, Naylor CE, Smedley JG, III, Lukoyanova N, Robertson S, Moss DS, McClane BA, Basak AK. 2011. Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins. J. Mol. Biol. 413:138-149.
55. Kitadokoro K, Nishimura K, Kamitani S, Fukui-Miyazaki A, Toshima H, Abe H, Kamata Y, Sugita-Konishi Y, Yamamoto S, Karatani H, Horiguchi Y. 2011. Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins. J. Biol. Chem. 286:19549-19555.
56. Hanna PC, Wnek AP, McClane BA. 1989. Molecular cloning of the 3′ half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity. J. Bacteriol. 171:6815-6820. (Pubitemid 20006969)
57. Hanna PC, Mietzner TA, Schoolnik GK, McClane BA. 1991. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region. J. Biol. Chem. 266:11037-11043. (Pubitemid 21906908)
58. Smedley JG, III, McClane BA. 2004. Fine-mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis. Infect. Immun. 72:6914-6923. (Pubitemid 39552358)
59. Smedley JG, III, Uzal FA, McClane BA. 2007. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect. Immun. 75:2381-2390. (Pubitemid 46744328)
60. Kokai-Kun JF, Benton K, Wieckowski EU, McClane BA. 1999. Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis. Infect. Immun. 67:5634-5641. (Pubitemid 29508080)
61. Chen J, Theoret JR, Shrestha A, Smedley JG, III, McClane BA. 2012. Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation. Infect. Immun. 80:4078-4088.
62. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. 1997. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J. Cell Biol. 136:1239-1247. (Pubitemid 27421912)
63. Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. 1997. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J. Biol. Chem. 272:26652-26658. (Pubitemid 27458889)
64. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tskuita S. 2000. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction membrane protein. FEBS Lett. 476:258-261. (Pubitemid 30410828)
65. Robertson S, Smedley JG, III, McClane BA. 2010. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin. Infect. Immun. 78:505-517.
66. Robertson SL, Smedley JG, III, Singh U, Chakrabarti G, Van Itallie CM, Anderson JM, McClane BA. 2007. Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants. Cell. Microbiol. 9:2734-2755. (Pubitemid 47500522)
67. Veshnyakova A, Piontek J, Protze J, Waziri N, Heise I, Krause G. 2012. Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins. J. Biol. Chem. 287:1698-1708.
68. Shrestha A, McClane BA. 2013. Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin. mBio 4(1):e000594-12. doi:10.1128/mBio.00594-12.
69. Anderson JM, Van Itallie CM. 2009. Physiology and function of the tight junction. Cold Spring Harb. Perspect. Biol. 1:a002584. doi:10.1101/cshperspect. a002584.
70. Van Itallie CM, Anderson JM. 2006. Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 68:403-429.
71. Van Itallie CM, Betts L, Smedley JG, III, McClane BA, Anderson JM. 2008. Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J. Biol. Chem. 283:268-274.
72. Takahashi A, Komiya E, Kakutani H, Yoshida T, Fujii M, Horiguchi Y, Mizuguchi H, Tsutsumi Y, Tsunoda S, Koizumi N, Isoda K, Yagi K, Watanabe Y, Kondoh M. 2008. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochem. Pharmacol. 75:1639-1648.
73. Wieckowski EU, Wnek AP, McClane BA. 1994. Evidence that an ∼50kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically-bound Clostridium perfringens enterotoxin. J. Biol. Chem. 269:10838-10848.
74. Singh U, Van Itallie CM, Mitic LL, Anderson JM, McClane BA. 2000. Caco-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J. Biol. Chem. 275:18407-18417. (Pubitemid 30414798)
75. McClane BA, Rood JI. 2001. Clostridial toxins involved in human enteric and histotoxic infections, p 169-209. In Bahl H, Duerre P (ed), Clostridia: biotechnology and medical applications. Wiley-VCH, Weinheim, Germany.
76. Hardy SP, Denmead M, Parekh N, Granum PE. 1999. Cationic currents induced by Clostridium perfringens type A enterotoxin in human intestinal Caco-2 cells. J. Med. Microbiol. 48:235-243. (Pubitemid 29371568)
77. Hardy SP, Ritchie C, Allen MC, Ashley RH, Granum PE. 2001. Clostridium perfringens type A enterotoxin forms mepacrine-sensitive pores in pure phospholipid bilayers in the absence of putative receptor proteins. Biochim. Biophys. Acta 1515:38-43. (Pubitemid 32938224)
78. Chakrabarti G, McClane BA. 2005. The importance of calcium influx, calpain, and calmodulin for the activation of Caco-2 cell death pathways by Clostridium perfringens enterotoxin. Cell. Microbiol. 7:129-146.
79. Chakrabarti G, Zhou X, McClane BA. 2003. Death pathways activated in Caco-2 cells by Clostridium perfringens enterotoxin. Infect. Immun. 71:4260-4270. (Pubitemid 36919888)
80. Singh U, Mitic LL, Wieckowski E, Anderson JM, McClane BA. 2001. Comparative biochemical and immunochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized Caco-2 cells versus Vero cells. J. Biol. Chem. 276:33402-33412.
81. McDonel JL. 1980. Binding of Clostridium perfringens 125I-enterotoxin to rabbit intestinal cells. Biochemistry 21:4801-4807. (Pubitemid 11218028)
82. Sherman S, Klein E, McClane BA. 1994. Clostridium perfringens type A enterotoxin induces concurrent development of tissue damage and fluid accumulation in the rabbit ileum. J. Diarrhoeal Dis. Res. 12:200-207.
83. Smedley JG, III, Saputo J, Parker JC, Fernandez-Miyakawa ME, Robertson SL, McClane BA, Uzal FA. 2008. Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect. Immun. 76:3793-3800.
84. McDonel JL, Demers GW. 1982. In vivo effects of enterotoxin from Clostridium perfringens type A in rabbit colon: binding vs biologic activity. J. Infect. Dis. 145:490-494. (Pubitemid 12158334)
85. Fernandez Miyakawa ME, Pistone Creydt V, Uzal FA, McClane BA, Ibarra C. 2005. Clostridium perfringens enterotoxin damages the human intestine in vitro. Infect. Immun. 73:8407-8410. (Pubitemid 41740333)
86. Hunter SEC, Brown JE, Oynston PCF, Sakurai J, Titball RW. 1993. Molecular genetic analysis of beta-toxin of Clostridium perfringens reveals sequence homology with alpha-toxin, gamma-toxin, and leukocidin of Staphylococcus aureus. Infect. Immun. 61:3958-3965. (Pubitemid 23260073)
87. Macias Rioseco M, Beingesser J, Uzal FA. 2012. Freezing or adding trypsin inhibitor to equine intestinal contents extends the lifespan of Clostridium perfringens beta toxin for diagnostic purposes. Anaerobe 18:357-360.
88. Sakurai J, Duncan CL. 1978. Some properties of the beta-toxin produced by Clostridium perfringens type C. Infect. Immun. 21:678-680. (Pubitemid 8405288)
89. Steinthorsdottir V, Fridriksdottir V, Gunnarsson E, Andresson OS. 1998. Site-directed mutagenesis of Clostridium perfringens beta-toxin: expression of wild-type and mutant toxins in Bacillus subtillis. FEMS Microbiol. Lett. 158:17-23. (Pubitemid 28088096)
90. Shatursky O, Bayles R, Rogers M, Jost BH, Songer JG, Tweten RK. 2000. Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect. Immun. 68:5546-5551.
91. Nagahama M, Hayashi S, Morimitsu S, Sakurai J. 2003. Biological activities and pore formation of Clostridium perfringens beta toxin in HL 60 cells. J. Biol. Chem. 278:36934-36941. (Pubitemid 37140028)
92. Uzal FA, McClane BA. 2011. Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections. Vet. Microbiol. 153:37-43.
93. Jost BH, Billington SJ, Trinh HT, Bueschel DM, Songer JG. 2005. Atypical cpb2 genes, encoding beta2-toxin in Clostridium perfringens isolates of nonporcine origin. Infect. Immun. 73:652-656. (Pubitemid 40041166)
94. Vilei EM, Schlatter Y, Perreten V, Straub R, Popoff MR, Gibert M, Grone A, Frey J. 2005. Antibiotic-induced expression of a cryptic cpb2 gene in equine beta2-toxigenic Clostridium perfringens. Mol. Microbiol. 57:1570-1581. (Pubitemid 41337387)
95. Popoff MR. 2011. Epsilon toxin: a fascinating pore-forming toxin. FEBS J. 278:4602-4615.
96. Bokori-Brown M, Savva CG, Fernandes da Costa SP, Naylor CE, Basak AK, Titball RW. 2011. Molecular basis of toxicity of Clostridium perfringens epsilon toxin. FEBS J. 278:4589-4601.
97. Minami J, Katayama S, Matsushita O, Matsushita C, Okabe A. 1997. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol. Immunol. 41:527-535. (Pubitemid 27318089)
98. Miyata S, Matsushita O, Minami J, Katayama S, Shimamoto S, Okabe A. 2001. Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane. J. Biol. Chem. 276:13778-13783.
99. Harkness JM, Li J, McClane BA. 2012. Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly. Anaerobe 18:546-552.
100. Robertson SL, Li J, Uzal FA, McClane BA. 2011. Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin. PLoS One 6:e22053. doi:10.1371/journal.pone.0022053.
101. Cole AR, Gibert M, Popoff M, Moss DS, Titball RW, Basak AK. 2004. Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat. Struct. Mol. Biol. 11:797-798. (Pubitemid 39014507)
102. Shortt SJ, Titball RW, Lindsay CD. 2000. An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells. Hum. Exp. Toxicol. 19:108-116. (Pubitemid 30189872)
103. Ivie SE, Fennessey CM, Sheng J, Rubin DH, McClain MS. 2011. Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens epsilon-toxin. PLoS One 6:e17787. doi:10.1371/journal. pone.0017787.
104. Ivie SE, McClain MS. 2012. Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1. Biochemistry 51:7588-7595.
105. Feigelstock D, Thompson P, Mattoo P, Zhang Y, Kaplan GG. 1998. The human homolog of HAVCR-1 codes for a hepatitis A virus cellular receptor. J. Virol. 72:6621-6628. (Pubitemid 28323979)
106. Tamai E, Ishida T, Miyata S, Matsushita O, Suda H, Kobayashi S, Sonobe H, Okabe A. 2003. Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance. Infect. Immun. 71:5371-5375. (Pubitemid 37070786)
107. Miyata S, Minami J, Tamia E, Matsushita P, Shimamoto S, Okabe A. 2002. Clostridium perfringens epsilon-toxin forms a hepatmeric pore within the detergent-insoluble microdomains of Madin-Darby canine kidney cells and rat synaptosomes. J. Biol. Chem. 277:39463-39468. (Pubitemid 35190922)
108. Fennessey CM, Sheng J, Rubin DH, McClain MS. 2012. Oligomerization of Clostridium perfringens epsilon toxin is dependent upon caveolins 1 and 2. PLoS One 7:e46866. doi:10.1371/journal.pone.0046866.
109. Shimada H, Kitada S. 2011. Mega assemblages of oligomeric aerolysin-like toxins stabilized by toxin-associating membrane proteins. J. Biochem. 149:103-115.
110. Knapp O, Maier E, Benz R, Geny B, Popoff MR. 2009. Identification of the channel-forming domain of Clostridium perfringens epsilon-toxin (ETX). Biochim. Biophys. Acta 1788:2584-2593.
111. Nestorovich EM, Karginov VA, Bezrukov SM. 2010. Polymer partitioning and ion selectivity suggest asymmetrical shape for the membrane pore formed by epsilon toxin. Biophys. J. 99:782-789.
112. Petit L, Maier E, Gibert M, Popoff MR, Benz R. 2001. Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J. Biol. Chem. 276:15736-15740.
113. Nagahama M, Itohayashi Y, Hara H, Higashihara M, Fukatani Y, Takagishi T, Oda M, Kobayashi K, Nakagawa I, Sakurai J. 2011. Cellular vacuolation induced by Clostridium perfringens epsilon-toxin. FEBS J. 278:3395-3407.
114. Goldstein J, Morris WE, Loidl CF, Tironi-Farinatti C, McClane BA, Uzal FA, Fernandez Miyakawa ME. 2009. Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats. PLoS One 4:e7065. doi:10.1371/journal.pone.0007065.
115. Sakurai J, Nagahama M, Oda M, Tsuge H, Kobayashi K. 2009. Clostridium perfringens iota-toxin: structure and function. Toxins 1:208-228.
116. Stiles BG, Wigelsworth DJ, Popoff MR, Barth H. 2011. Clostridial binary toxins: iota and C2 family portraits. Front. Cell. Infect. Microbiol. 1:11. doi:10.3389/fcimb.2011.00011.
117. Barth H, Stiles BG. 2008. Binary actin-ADP-ribosylating toxins and their use as molecular Trojan horses for drug delivery into eukaryotic cells. Curr. Med. Chem. 15:459-469. (Pubitemid 351472412)
118. Aktories K, Schwan C, Papatheodorou P, Lang AE. 2012. Bidirectional attack on the actin cytoskeleton. Bacterial protein toxins causing polymerization or depolymerization of actin. Toxicon 60:572-581.
119. Papatheodorou P, Carette JE, Bell GW, Schwan C, Guttenberg G, Brummelkamp TR, Aktories K. 2011. Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proc. Natl. Acad. Sci. U. S. A. 108:16422-16427.
120. Papatheodorou P, Wilczek C, Nolke T, Guttenberg G, Hornuss D, Schwan C, Aktories K. 2012. Identification of the cellular receptor of Clostridium spiroforme toxin. Infect. Immun. 80:1418-1423.
121. Wigelsworth DJ, Ruthel G, Schnell L, Herrlich P, Blonder J, Veenstra TD, Carman RJ, Wilkins TD, Van Nhieu GT, Pauillac S, Gibert M, Sauvonnet N, Stiles BG, Popoff MR, Barth H. 2012. CD44 promotes intoxication by the clostridial iota-family toxins. PLoS One 7:e51356. doi:10.1371/journal.pone.0051356.
122. Hale ML, Marvaud JC, Popoff MR, Stiles BG. 2004. Detergent-resistant membrane microdomains facilitate Ib oligomer formation and biological activity of Clostridium perfringens iota-toxin. Infect. Immun. 72:2186-2193. (Pubitemid 38419933)
123. Nagahama M, Yamaguchi A, Hagiyama T, Ohkubo N, Kobayashi K, Sakurai J. 2004. Binding and internalization of Clostridium perfringens iota-toxin in lipid rafts. Infect. Immun. 72:3267-3275. (Pubitemid 38697748)
124. Marvaud JC, Stiles BG, Chenal A, Gillet D, Gibert M, Smith LA, Popoff MR. 2002. Clostridium perfringens iota toxin. Mapping of the Ia domain involved in docking with Ib and cellular internalization. J. Biol. Chem. 277:43659-43666. (Pubitemid 36157781)
125. Gibert M, Monier MN, Ruez R, Hale ML, Stiles BG, Benmerah A, Johannes L, Lamaze C, Popoff MR. 2011. Endocytosis and toxicity of clostridial binary toxins depend on a clathrin-independent pathway regulated by Rho-GDI. Cell. Microbiol. 13:154-170.
126. Schering B, Barmann M, Chhatwal GS, Geipel U, Aktories K. 1988. ADP-ribosylation of skeletal muscle and non-muscle actin by Clostridium perfringens iota toxin. Eur. J. Biochem. 171:225-229. (Pubitemid 18042886)
127. Hilger H, Pust S, von Figura G, Kaiser E, Stiles BG, Popoff MR, Barth H. 2009. The long-lived nature of Clostridium perfringens iota toxin in mammalian cells induces delayed apoptosis. Infect. Immun. 77:5593-5601.
128. Keyburn AL, Bannam TL, Moore RJ, Rood JI. 2010. NetB, a poreforming toxin from necrotic enteritis strains of Clostridium perfringens. Toxins 2:1913-1927.
129. Keyburn AL, Yan XX, Bannam TL, Van Immerseel F, Rood JI, Moore RJ. 2010. Association between avian necrotic enteritis and Clostridium perfringens strains expressing NetB toxin. Vet. Res. 41:21. doi:10.1051/vetres/2009069.
130. Martin TG, Smyth JA. 2009. Prevalence of netB among some clinical isolates of Clostridium perfringens from animals in the United States. Vet. Microbiol. 136:202-205.
131. Abildgaard L, Sondergaard TE, Engberg RM, Schramm A, Hojberg O. 2010. In vitro production of necrotic enteritis toxin B, NetB, by netB-positive and netB-negative Clostridium perfringens originating from healthy and diseased broiler chickens. Vet. Microbiol. 144:231-235.
132. Engstrom BE, Johansson A, Aspan A, Kaldhusdal M. 2012. Genetic relatedness and netB prevalence among environmental Clostridium perfringens strains associated with a broiler flock affected by mild necrotic enteritis. Vet. Microbiol. 159:260-264.
133. Yan X, Porter CJ, Hardy SP, Steer D, Smith AI, Quinsey NS, Hughes V, Cheung JK, Keyburn AL, Kaldhusdal M, Moore RJ, Bannam TL, Whisstock JC, Rood JI. 2013. Structural and functional analysis of the pore-forming toxin NetB from Clostridium perfringens. mBio 4 (1):e00019-13. doi:10.1128/mBio.00019-13.
134. Savva CG, Fernandes da Costa SP, Bokori-Brown M, Naylor CE, Cole AR, Moss DS, Titball RW, Basak AK. 2013. Molecular architecture and functional analysis of NetB, a pore-forming toxin from Clostridium perfringens. J. Biol. Chem. 288:3512-3522.
135. Paredes-Sabja D, Sarker N, Sarker MR. 2011. Clostridium perfringens tpeL is expressed during sporulation. Microb. Pathog. 51:384-388.
136. Guttenberg G, Hornei S, Jank T, Schwan C, Lu W, Einsle O, Papatheodorou P, Aktories K. 2012. Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells. J. Biol. Chem. 287:24929-24940.
137. Nagahama M, Ohkubo A, Oda M, Kobayashi K, Amimoto K, Miyamoto K, Sakurai J. 2011. Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins. Infect. Immun. 79:905-910.
138. Coursodon CF, Glock RD, Moore KL, Cooper KK, Songer JG. 2012. TpeL-producing strains of Clostridium perfringens type A are highly virulent for broiler chicks. Anaerobe 18:117-121.
139. Manich M, Knapp O, Gibert M, Maier E, Jolivet-Reynaud C, Geny B, Benz R, Popoff MR. 2008. Clostridium perfringens delta toxin is sequence related to beta toxin, NetB, and Staphylococcus pore-forming toxins, but shows functional differences. PLoS One 3:e3764. doi:10.1371/journal.pone.0003764.
140. Adams JJ, Gregg K, Bayer EA, Boraston AB, Smith SP. 2008. Structural basis of Clostridium perfringens toxin complex formation. Proc. Natl. Acad. Sci. U. S. A. 105:12194-12199.
141. Chiarezza M, Lyras D, Pidot SJ, Flore-Diaz M, Awad MM, Kennedy CL, Cordner LM, Phumoonna T, Poon R, Hughes ML, Emmins JJ, Alape-Giron A, Rood JI.
142. Li J, Sayeed S, Robertson S, Chen J, McClane BA. 2011. Sialidases affect the host cell adherence and epsilon toxin-induced cytotoxicity of Clostridium perfringens type D strain CN3718. PLoS Pathog. 7:e1002429. doi:10.1371/journal. ppat.1002429.
143. Shimizu T, Ba-Thein W, Tamaki M, Hayashi H. 1994. The virR gene, a member of a class of two-component response regulators, regulates the production of perfringolysin O, collagenase, and hemagglutinin in Clostridium perfringens. J. Bacteriol. 176:1616-1623. (Pubitemid 24100210)
144. Lyristis M, Bryant AE, Sloan J, Awad MM, Nisbet IT, Stevens DL, Rood JI. 1994. Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens. Mol. Microbiol. 12:761-777. (Pubitemid 24214470)
145. Cheung JK, Awad MM, McGowan S, Rood JI. 2009. Functional analysis of the VirSR phosphorelay from Clostridium perfringens. PLoS One 4:e5849. doi:10.1371/journal.pone.0005849.
146. Cheung JK, Dupuy B, Deveson DS, Rood JI. 2004. The spatial organization of the VirR boxes is critical for VirR-mediated expression of the perfringolysin O gene, pfoA, from Clostridium perfringens. J. Bacteriol. 186:3321-3330. (Pubitemid 38661527)
147. McGowan S, Lucet IS, Cheung JK, Awad MM, Whisstock JC, Rood JI. 2002. The FxRxHrS motif: a conserved region essential for DNA binding of the VirR response regulator from Clostridium perfringens. J. Mol. Biol. 322:997-1011. (Pubitemid 35266508)
148. Shimizu T, Yaguchi H, Ohtani K, Banu S, Hayashi H. 2002. Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins. Mol. Microbiol. 43:257-265. (Pubitemid 34212207)
149. Shimizu T, Shima K, Yoshino K, Yonezawa K, Hayashi H. 2002. Proteome and transcriptome analysis of the virulence genes regulated by the VirR/VirS system in Clostridium perfringens. J. Bacteriol. 184:2587-2594. (Pubitemid 34457024)
150. Ohtani K, Kawsar HI, Okumura K, Hayashi H, Shimizu T. 2003. The VirR/VirS regulatory cascade affects transcription of plasmid-encoded putative virulence genes in Clostridium perfringens. FEMS Microbiol. Lett. 222:137-141. (Pubitemid 36577363)
151. Cheung JK, Keyburn AL, Carter G, Lanckriet A, Van Immerseel F, Moore R, Rood JI. 2010. The VirSR two-component signal transduction system regulates NetB toxin production in Clostridium perfringens. Infect. Immun. 78:3064-3072.
152. Ma M, Vidal J, Saputo J, McClane BA, Uzal F. 2011. The VirS/VirR two-component system regulates the anaerobic cytotoxicity, intestinal pathogenicity, and enterotoxemic lethality of type C isolate CN3685. mBio 2(1):e00338-10. doi:10.1128/mBio.00338-10.
153. Vidal JE, Ohtani K, Shimizu T, McClane BA. 2009. Contact with enterocyte-like Caco-2 cells induces rapid upregulation of toxin production by Clostridium perfringens type C isolates. Cell. Microbiol. 11:1306-1328.
154. Chen J, Rood JI, McClane BA. 2011. Epsilon-toxin production by Clostridium perfringens type D strain CN3718 is dependent upon the agr operon but not the VirS/VirR two-component regulatory system. mBio 2(6):e00275-11. doi:10.1128/mBio.00275-11.
155. Ohtani K, Yuan Y, Hassan S, Wang R, Wang Y, Shimizu M. 2009. Virulence gene regulation by the agr system in Clostridium perfringens. J. Bacteriol. 191:3919-3927.
156. Vidal JE, Chen J, Li J, McClane BA. 2009. Use of an EZ-Tn5-based random mutagenesis system to identify a novel toxin regulatory locus in Clostridium perfringens strain 13. PLoS One 4:e6232. doi:10.1371/journal.pone.0006232.
157. Li J, Chen J, Vidal JE, McClane BA. 2011. The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603. Infect. Immun. 79:2451-2459.
158. Vidal JE, Ma M, Saputo J, Garcia J, Uzal FA, McClane BA. 2011. Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685. Mol. Microbiol. 83:179-194.
159. Chen J, McClane BA. 2012. Role of the agr-like quorum-sensing system in regulating toxin production by Clostridium perfringens type B strains CN1793 and CN1795. Infect. Immun. 80:3008-3017.
160. McNee JW, Dunn JS. 1917. The method of spread of gas gangrene into living muscle. Br. Med. J. i:726-729.
161. Maclennan JD. 1962. The histotoxic clostridial infections of man. Bacteriol. Rev. 26:177-276.
162. Stevens DL, Rood JI. 2006. Histotoxic clostridia, p 715-725. In Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (ed), Gram-positive pathogens, 2nd ed. ASM Press, Washington, DC.
163. Rood JI. 2007. Clostridium perfringens and histotoxic disease, p 753-770. In Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrandt E (ed), The prokaryotes: a handbook on the biology of bacteria, 3rd ed. Springer, New York, NY.
164. Stevens DL, Tweten RK, Awad MM, Rood JI, Bryant AE. 1997. Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J. Infect. Dis. 176:189-195. (Pubitemid 27272868)
165. Awad MM, Ellemor DM, Boyd RL, Emmins JJ, Rood JI. 2001. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect. Immun. 69:7904-7910. (Pubitemid 33086624)
166. Parish S, Valberg S. 2009. Inflammatory myopathies. Clostridial myonecrosis, p 1400-1492. In Smith BP (ed), Large animal internal medicine. Mosby-Elsevier, St Louis, MO.
167. Harwood DG. 1984. Apparent iatrogenic clostridial myositis in cattle. Vet. Rec. 115:412. (Pubitemid 14015256)
168. Odani JS, Blanchard PC, Adaska JM, Moeller RB, Uzal FA. 2009. Malignant edema in postpartum dairy cattle. J. Vet. Diagn. Invest. 21:920-924.
169. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M, Roy S, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States - major pathogens. Emerg. Infect. Dis. 17:7-15.
170. Grant K, Kenyon S, Nwafor I, Plowman J, Ohai C, Halford-Maw R, Peck M, McLauchlin J. 2008. The identification and characterization of Clostridium perfringens by real-time PCR, location of enterotoxin gene, and heat resistance. Foodborne Pathog. Dis. 5:629-639.
171. Sarker MR, Shivers RP, Sparks SG, Juneja VK, McClane BA. 2000. Comparative experiments to examine the effects of heating on vegetative cells and spores of Clostridium perfringens isolates carrying plasmid versus chromosomal enterotoxin genes. Appl. Environ. Microbiol. 66:3234-3240. (Pubitemid 30624563)
172. Li J, McClane BA. 2006. Further comparison of temperature effects on growth and survival of Clostridium perfringens type A isolates carrying a chromosomal or plasmid-borne enterotoxin gene. Appl. Environ. Microbiol. 72:4561-4568. (Pubitemid 44078778)
173. Li J, McClane BA. 2006. Comparative effects of osmotic, sodium nitrite-induced, and pH-induced stress on growth and survival of Clostridium perfringens type A isolates carrying chromosomal or plasmid-borne enterotoxin genes. Appl. Environ. Microbiol. 72:7620-7625. (Pubitemid 44927665)
174. Novak JS, Juneja VK, McClane BA. 2003. An ultrastructural comparison of spores from various strains of Clostridium perfringens and correlations with heat resistance parameters. Int. J. Food Microbiol. 86:239-247. (Pubitemid 36945568)
175. Orsburn B, Melville SB, Popham D. 2008. Factors contributing to heat resistance of Clostridium perfringens endospores. Appl. Environ. Microbiol. 74:3328-3335. (Pubitemid 351812785)
176. Li J, McClane BA. 2008. A novel small acid soluble protein variant is important for spore resistance of most Clostridium perfringens food poisoning isolates. PLoS Pathog. 4:e1000056. doi:10.1371/journal.ppat.1000056.
177. Li J, Paredes-Sabja D, Sarker MR, McClane BA. 2009. Further charactrization of Clostridium perfringens small acid soluble protein-4 (Ssp4) properties and expression. PLoS One 4:e6249. doi:10.1371/journal.pone.0006249.
178. Li J, McClane BA. 2010. Evaluating the involvement of alternative sigma factors SigF and SigG in Clostridium perfringens sporulation and enterotoxin synthesis. Infect. Immun. 78:4286-4293.
179. Harry KH, Zhou R, Kroos L, Melville SB. 2009. Sporulation and enterotoxin (CPE) synthesis are controlled by the sporulation-specific factors SigE and SigK in Clostridium perfringens. J. Bacteriol. 191:2728-2742.
180. Zhao Y, Melville SB. 1998. Identification and characterization of sporulation-dependent promoters upstream of the enterotoxin gene (cpe) of Clostridium perfringens. J. Bacteriol. 180:136-142. (Pubitemid 28023793)
181. Huang IH, Waters M, Grau RR, Sarker MR. 2004. Disruption of the gene (spo0A) encoding sporulation transcription factor blocks endospore formation and enterotoxin production in enterotoxigenic Clostridium perfringens type A. FEMS Microbiol. Lett. 233:233-240. (Pubitemid 38452625)
182. Bos J, Smithee L, McClane BA, Distefano RF, Uzal F, Songer JG, Mallonee S, Crutcher JM. 15 April 2005. Fatal necrotizing enteritis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection. Clin. Infect. Dis. 15:e78-e83.
183. CDC. 2012. Fatal foodborne Clostridium perfringens illness at a state psychiatric hospital - Louisiana, 2010. MMWR Morb. Mortal. Wkly. Rep. 61:605-608.
184. Caserta JA, Robertson SL, Saputo J, Shrestha A, McClane BA, Uzal FA. 2011. Development and application of a mouse interstinal loop model to study the in vivo action of Clostridium perfringens enterotoxin. Infect. Immun. 79:3020-3027.
185. Carman RJ. 1997. Clostridium perfringens in spontaneous and antibiotic-associated diarrhoea of man and other animals. Rev. Med. Microbiol. 8(Suppl 1):S43-S45. (Pubitemid 28035082)
186. Carman RJ, Sayeed S, Li J, Genheimer CW, Hiltonsmith MF, Wilkins TD, McClane BA. 2008. Clostridium perfringens toxin genotypes in the feces of healthy North Americans. Anaerobe 14:102-108.
187. Heikinheimo A, Lindstrom M, Granum PE, Korkeala H. 2006. Humans as reservoir for enterotoxin gene-carrying Clostridium perfringens type A. Emerg. Infect. Dis. 12:1724-1729. (Pubitemid 44674249)
188. Borriello SP, Barclay FE, Welch AR, Stringer MF, Watson GN, Williams RKT, Seal DV, Sullens K. 1985. Epidemiology of diarrhea caused by enterotoxigenic Clostridium perfringens. J. Med. Microbiol. 20:363-372. (Pubitemid 16211407)
189. Johnson S, Gerding DN. 1997. Enterotoxemic infections, p 117-140. In Rood JI, McClane BA, Songer JG, Titball RW (ed), The clostridia: molecular biology and pathogenesis. Academic Press, London, England.
190. Lawrence GW. 1997. The pathogenesis of enteritis necroticans, p 197-207. In Rood JI, McClane BA, Songer JG, Titball RW (ed), The clostridia: molecular biology and pathogenesis. Academic Press, London, England.
191. Zeissler J, Rassfeld-Sternberg L. 1949. Enteritis necroticans due to Clostridium welchii type F. Br. Med. J. i:267-269.
192. Van Immerseel F, Rood JI, Moore RJ, Titball RW. 2009. Rethinking our understanding of the pathogenesis of necrotic enteritis in chickens. Trends Microbiol. 17:32-36.
193. Cooper KK, Songer JG. 2009. Necrotic enteritis in chickens: a paradigm of enteric infection by Clostridium perfringens type A. Anaerobe 15:55-60.
194. Keyburn AL, Sheedy SA, Ford ME, Williamson MM, Awad MM, Rood JI, Moore RJ. 2006. Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect. Immun. 74:6496-6500. (Pubitemid 44657433)
195. Kulkarni RR, Parreira VR, Sharif S, Prescott JF. 2007. Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis. Clin. Vaccine Immunol. 14:1070-1077. (Pubitemid 47518072)
196. Zekarias B, Mo H, Curtiss R, III. 2008. Recombinant attenuated Salmonella enterica serovar Typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens. Clin. Vaccine Immunol. 15:805-816. (Pubitemid 351967031)
197. Lee KW, Lillehoj HS, Park MS, Jang SI, Ritter GD, Hong YH, Jeong W, Jeoung HY, An DJ, Lillehoj EP. 2012. Clostridium perfringens alpha-toxin and NetB toxin antibodies and their possible role in protection against necrotic enteritis and gangrenous dermatitis in broiler chickens. Avian Dis. 56:230-233.
198. Jang SI, Lillehoj HS, Lee SH, Lee KW, Lillehoj EP, Hong YH, An DJ, Jeong W, Chun JE, Bertrand F, Dupuis L, Deville S, Arous JB. 2012. Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens. Vaccine 30:5401-5406.
199. Miyakawa ME, Saputo J, Leger JS, Puschner B, Fisher DJ, McClane BA, Uzal FA. 2007. Necrotizing enterocolitis and death in a goat kid associated with enterotoxin (CPE)-producing Clostridium perfringens type A. Can. Vet. J. 48:1266-1269.
200. Marks S, Kather E, Kass P, Melli A. 2002. Genotypic and phenotypic characterization of Clostridium perfringens and Clostridium difficile in diarrheic and healthy dogs. J. Vet. Intern. Med. 16:533-540. (Pubitemid 135747431)
201. Weese JS, Staempfli HR, Prescott JF. 2001. A prospective study of the roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea. Equine Vet. J. 33:403-409. (Pubitemid 33644661)
202. Guss SB. 1977. Management and diseases of dairy goats, p 106-109. Dairy Goat Journal Publishing Corp., Scottsdale, AZ.
203. McGowan B, Moulton JE, Rood SE. 1958. Lamb losses associated with Clostridium perfringens type A. J. Am. Vet. Med. Assoc. 133:219-221.
204. Bueschel DM, Jost BH, Billington SJ, Trinh HT, Songer JG. 2003. Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens field isolates: correlation of genotype with phenotype. Vet. Microbiol. 94:121-129. (Pubitemid 36627812)
205. Dray T. 2004. Clostridium perfringens type A and beta2 toxin associated with enterotoxemia in a 5-week-old goat. Can. Vet. J. 45:251-253. (Pubitemid 38443478)
206. Waters M, Savoie A, Garmory HS, Bueschel D, Popoff MR, Songer JG, Titball RW, McClane BA, Sarker MR. 2003. Genotyping and phenotyping of beta2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets. J. Clin. Microbiol. 41:3584-3591. (Pubitemid 36994686)
207. Songer JG, Uzal FA. 2005. Clostridial enteric infections in pigs. J. Vet. Diagn. Invest. 17:528-536. (Pubitemid 41666900)
208. Songer JG. 1998. Clostridial diseases of small ruminants. Vet. Res. 29:219-232. (Pubitemid 128528105)
209. Lewis CJ. 2000. Clostridial diseases, p 131-142. In Martin WB, Aitken ID (ed), Diseases of sheep. Blackwell Science, Oxford, England.
210. Sayeed S, Uzal FA, Fisher DJ, Saputo J, Vidal JE, Chen Y, Gupta P, Rood JI, McClane BA. 2008. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol. Microbiol. 67:15-30. (Pubitemid 350231133)
211. Gurtner C, Popescu F, Wyder M, Sutter E, Zeeh F, Frey J, von Schubert C, Posthaus H. 2010. Rapid cytopathic effects of Clostridium perfringens beta-toxin on porcine endothelial cells. Infect. Immun. 78:2966-2973.
212. Schumacher VL, Martel A, Pasmans F, Van Immerseel F, Posthaus H. Endothelial binding of beta toxin to small intestinal mucosal endothelial cells in early stages of experimentally induced Clostridium perfringens type C enteritis in pigs. Vet. Pathol., in press.
213. Uzal FA, Kelly WR. 1997. Effects of the intravenous administration of Clostridium perfringens type D epsilon toxin on young goats and lambs. J. Comp. Pathol. 116:63-71. (Pubitemid 27110526)
214. Sayeed S, Fernandez-Miyakawa ME, Fisher DJ, Adams V, Poon R, Rood JI, Uzal FA, McClane BA. 2005. Epsilon-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model. Infect. Immun. 73:7413-7421. (Pubitemid 41587644)
215. Buxton D, Linklater KA, Dyson DA. 1978. Pulpy kidney disease and its diagnosis by histological examination. Vet. Rec. 102:241.
216. Finnie JW. 1984. Histopathological changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J. Comp. Pathol. 94:363-370. (Pubitemid 15070105)
217. Finnie JW. 1984. Ultrastructural changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J. Comp. Pathol. 94:445-452. (Pubitemid 15070112)
218. Finnie JW, Hajduk P. 1992. An immunohistochemical study of plasma albumin extravasation in the brain of mice after the administration of Clostridium perfringens type D epsilon toxin. Aust. Vet. J. 69:261-262.
219. Uzal FA, Songer G. 2008. Diagnosis of Clostridium perfringens intestinal infections in sheep and goat. J. Vet. Diagn. Invest. 20:253-265. (Pubitemid 352844373)
220. Songer JG, Miskimmins DW. 2004. Clostridium perfringens type E enteritis in calves: two cases and a brief review of the literature. Anaerobe 10:239-242. (Pubitemid 39024255)
221. Vidal JE, McClane BA, Saputo J, Parker J, Uzal FA. 2008. Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon. Infect. Immun. 76:4396-4404.
222. Garcia JP, Beingesser J, Fisher DJ, Sayeed S, McClane BA, Posthaus H, Uzal FA. 2012. The effect of Clostridium perfringens type C strain CN3685 and its isogenic beta toxin null mutant in goats. Vet. Microbiol. 157:412-419.
223. Uzal FA, Saputo J, Sayeed S, Vidal JE, Fisher DJ, Poon R, Adams V, Fernandez-Miyakawa ME, Rood JI, McClane BA. 2009. Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C enterotoxemias. Infect. Immun. 77:5291-5299.
224. Abraham LJ, Wales AJ, Rood JI. 1985. Worldwide distribution of the conjugative Clostridium perfringens tetracycline resistance plasmid, pCW3. Plasmid 14:37-46. (Pubitemid 15023702)
225. Rokos EA, Rood JI, Duncan CL. 1978. Multiple plasmids in different toxigenic types of Clostridium perfringens. FEMS Microbiol. Lett. 4:323-326. (Pubitemid 9061027)
226. Brefort G, Magot M, Ionesco H, Sebald M. 1977. Characterization and transferability of Clostridium perfringens plasmids. Plasmid 1:52-66.
227. Rood JI, Maher EA, Somers EB, Campos E, Duncan CL. 1978. Isolation and characterization of multiply antibiotic-resistant Clostridium perfringens strains from porcine feces. Antimicrob. Agents Chemother. 13:871-880. (Pubitemid 8323564)
228. Abraham LJ, Rood JI. 1985. Cloning and analysis of the Clostridium perfringens tetracycline resistance plasmid, pCW3. Plasmid 13:155-162. (Pubitemid 15055176)
229. Garnier T, Saurin W, Cole ST. 1987. Molecular characterization of the resolvase gene, res, carried by a multicopy plasmid from Clostridium perfringens: common evolutionary origin for prokaryotic site-specific recombinases. Mol. Microbiol. 1:371-376.
230. Garnier T, Cole ST. 1988. Complete nucleotide sequence and genetic organization of the bacteriocinogenic plasmid, pIP404, from Clostridium perfringens. Plasmid 19:134-150.
231. Garnier T, Cole ST. 1988. Identification and molecular genetic analysis of replication functions of the bacteriocinogenic plasmid pIP404 from Clostridium perfringens. Plasmid 19:151-160.
232. Garnier T, Cole ST. 1986. Characterization of a bacteriocinogenic plasmid from Clostridium perfringens and molecular genetic analysis of the bacteriocin-encoding gene. J. Bacteriol. 168:1189-1196. (Pubitemid 17226802)
233. Duncan CL, Rokos EA, Christenson CM, Rood JI. 1978. Multiple plasmids in different toxigenic types of Clostridium perfringens: possible control of beta toxin production, p 246-248. In Schlessinger D (ed), Microbiology - 1978. American Society for Microbiology, Washington, DC.
234. Katayama SI, Dupuy B, Daube G, China B, Cole ST. 1996. Genome mapping of Clostridium perfringens strains with I-Ceu I shows many virulence genes to be plasmid-borne. Mol. Gen. Genet. 251:720-726.
235. Parreira VR, Costa M, Eikmeyer F, Blom J, Prescott JF. 2012. Sequence of two plasmids from Clostridium perfringens chicken necrotic enteritis isolates and comparison with C. perfringens conjugative plasmids. PLoS One 7:e49753. doi:10.1371/journal.pone.0049753.
236. Bannam TL, Teng WL, Bulach D, Lyras D, Rood JI. 2006. Functional identification of conjugation and replication regions of the tetracycline resistance plasmid pCW3 from Clostridium perfringens. J. Bacteriol. 188:4942-4951. (Pubitemid 43956091)
237. Miyamoto K, Wen Q, McClane BA. 2004. Multiplex PCR genotyping assay that distinguishes between isolates of Clostridium perfringens type A carrying a chromosomal enterotoxin gene (cpe) locus, a plasmid cpe locus with an IS1470-like sequence, or a plasmid cpe locus with an IS1151 sequence. J. Clin. Microbiol. 41:1552-1558. (Pubitemid 38500795)
238. Brynestad S, Granum PE. 1999. Evidence that Tn5565, which includes the enterotoxin gene in Clostridium perfringens, can have a circular form which may be a transposition intermediate. FEMS Microbiol. Lett. 170:281-286. (Pubitemid 29044104)
239. Rood JI, Scott VN, Duncan CL. 1978. Identification of a transferable tetracycline resistance plasmid (pCW3) from Clostridium perfringens. Plasmid 1:563-570. (Pubitemid 9020005)
240. Abraham LJ, Rood JI. 1987. Identification of Tn4451 and Tn4452, chloramphenicol resistance transposons from Clostridium perfringens. J. Bacteriol. 169:1579-1584. (Pubitemid 17063486)
241. Brynestad S, Sarker MR, McClane BA, Granum PE, Rood JI. 2001. The enterotoxin (CPE) plasmid from Clostridium perfringens is conjugative. Infect. Immun. 69:3483-3487. (Pubitemid 32332254)
242. Teng WL, Bannam TL, Parsons JA, Rood JI. 2008. Functional characterization and localization of the TcpH conjugation protein from Clostridium perfringens. J. Bacteriol. 190:5075-5086. (Pubitemid 351991075)
243. Parsons JA, Bannam TL, Devenish RJ, Rood JI. 2007. TcpA, an FtsK/SpoIIIE homolog, is essential for transfer of the conjugative plasmid pCW3 in Clostridium perfringens. J. Bacteriol. 189:7782-7790. (Pubitemid 350035088)
244. Porter CJ, Bantwal R, Bannam TL, Rosado CJ, Pearce MC, Adams V, Lyras D, Whisstock JC, Rood JI. 2012. The conjugation protein TcpC from Clostridium perfringens is structurally related to the type IV secretion system protein VirB8 from Gram-negative bacteria. Mol. Microbiol. 83:275-288.
245. Bantwal R, Bannam TL, Porter CJ, Quinsey NS, Lyras D, Adams V, Rood JI. 2012. The peptidoglycan hydrolase TcpG is required for efficient conjugative transfer of pCW3 in Clostridium perfringens. Plasmid 67:139-147.
246. Llosa M, Gomis-Ruth FX, Coll M, de la Cruz F. 2002. Bacterial conjugation: a two-step mechanism for DNA transport. Mol. Microbiol. 45:1-8. (Pubitemid 35025928)
247. Iyer LM, Makarova KS, Koonin EV, Aravind L. 2004. Comparative genomics of the FtsK-HerA superfamily of pumping ATPases: implications for the origins of chromosome segregation, cell division and viral capsid packaging. Nucleic Acids Res. 32:5260-5279. (Pubitemid 39445514)
248. Steen JA, Bannam TL, Teng WL, Devenish RJ, Rood JI. 2009. The putative coupling protein TcpA interacts with other pCW3-encoded proteins to form an essential part of the conjugation complex. J. Bacteriol. 191:2926-2933.
249. Kumar RB, Xie YH, Das A. 2000. Subcellular localization of the Agrobacterium tumefaciens T-DNA transport pore proteins: VirB8 is essential for the assembly of the transport pore. Mol. Microbiol. 36:608-617. (Pubitemid 30258845)
250. Sivanesan D, Hancock MA, Villamil Giraldo AM, Baron C. 2010. Quantitative analysis of VirB8-VirB9-VirB10 interactions provides a dynamic model of type IV secretion system core complex assembly. Biochemistry 49:4483-4493.
251. del Solar G, Giraldo R, Ruiz-Echevarria MJ, Espinosa M, Diaz-Orejas R. 1998. Replication and control of circular bacterial plasmids. Microbiol. Mol. Biol. Rev. 62:434-464. (Pubitemid 28270281)
252. Ionesco H. 1980. Transferable tetracycline resistance in "Clostridium difficile". Ann. Microbiol. (Paris) 131A:171-179. (In French.) (Pubitemid 10047407)
253. Lyras D, Storie C, Huggins AS, Crellin PK, Bannam TL, Rood JI. 1998. Chloramphenicol resistance in Clostridium difficile is encoded on Tn4453 transposons that are closely related to Tn4451 from Clostridium perfringens. Antimicrob. Agents Chemother. 42:1563-1567. (Pubitemid 28311541)
254. Sasaki Y, Yamamoto K, Tamura Y, Takahashi T. 2001. Tetracycline- resistance genes of Clostridium perfringens, Clostridium septicum and Clostridium sordellii isolated from cattle affected with malignant edema. Vet. Microbiol. 83:61-69. (Pubitemid 32778461)
255. Raffestin S, Marvaud JC, Cerrato R, Dupuy B, Popoff MR. 2004. Organization and regulation of the neurotoxin genes in Clostridium botulinum and Clostridium tetani. Anaerobe 10:93-100. (Pubitemid 38519809)
256. Marshall KM, Bradshaw M, Johnson EA. 2010. Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum. PLoS One 5:e11087. doi:10.1371/journal.pone.0011087.
257. McClane BA, Lyerly DM, Wilkins TD. 2006. Enterotoxic clostridia: Clostridium perfringens type A and Clostridium difficile, p 703-714. In Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood J (ed), Gram-positive pathogens, 3rd ed. ASM Press, Washington, DC.
258. Xiao Y, Wagendorp A, Moezelaar R, Abee T, Wells-Bennik MH. 2012. A wide variety of Clostridium perfringens type A food-borne isolates that carry a chromosomal cpe gene belong to one multilocus sequence typing cluster. Appl. Environ. Microbiol. 78:7060-7068.
259. Lahti P, Lindstrom M, Somervuo P, Heikinheimo A, Korkeala H. 2012. Comparative genomic hybridization analysis shows different epidemiology of chromosomal and plasmid-borne cpe-carrying Clostridium perfringens type A. PLoS One 7:e46162. doi:10.1371/journal.pone.0046162.
260. Lepp D, Gong J, Songer JG, Boerlin P, Parreira VR, Prescott JF. 2013. Identification of accessory genome regions in poultry Clostridium perfringens isolates carrying the NetB plasmid. J. Bacteriol. 195:1152-1166.